GlassScriptPhysician profile
Steven C Kronlage
NPI 1861585986
$102,883.35
in general payments reported to CMS, 2019-2025
9 companies · $517 in 2025
The $517 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $14K · 2021: $21K · 2022: $22K · 2023: $24K · 2024: $7,133 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $32K · Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $31,512.17 |
| Food and Beverage | $583.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $101,016.06 | 2019-2024 | Arthrex, Extremities & Trauma Instruments Soft Tissue |
| Cgg Medical INC | $1,426.81 | 2019-2025 | |
| Bioventus LLC | $199.65 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $126.60 | 2025 | Mako |
| Djo, LLC | $44.39 | 2022 | |
| Depuy Synthes Sales INC. | $20.03 | 2023 | Motoband, Acclaim |
| Orthofix Medical, INC. | $17.75 | 2022 | |
| Stimwave Technologies Incorporated | $16.90 | 2022 | |
| Csl Behring | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kronlage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.